Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Cell Research|February 10, 2006
uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell lineSo Young Yoon, Yoo Jung Lee, Jae Hong Seo, et al.
Yonsei Medical Journal|November 1, 2005
Hematopoietic differentiation of embryoid bodies derived from the human embryonic stem cell line SNUhES3 in co-culture with human bone marrow stromal cellsSeok Jin Kim, Byung Soo Kim, Suck Won Ryu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 7, 2016
A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancerK H Park, S Lee, J H Park, et al.
Cancer Research and Treatment|May 23, 2014
Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin TreatmentJung Hyun Lee, Sung Gu Kang, Seung Tae Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2024
Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancerSara M Tolaney, Valentina Guarneri, Jae Hong Seo, et al.
Cancer Chemotherapy and Pharmacology|December 25, 2009
Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in KoreaKyong Hwa Park, Jeong Sun Kim, Yong Park, et al.
Clinical Rheumatology|February 3, 2006
Acute arthritis of carpal bones secondary to metastatic gastric cancerKyong-Hwa Park, Young-Hee Rho, Seong-Jae Choi, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysisHee Yeon Seo, Dae Sik Kim, Yoon Seok Choi, et al.
British Journal of Haematology|June 29, 2006
Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional studyHwa Jung Sung, Seok Jin Kim, Hee Yun Seo, et al.
Oncology Reports|November 14, 2025
C‑terminal HSP90 inhibitor NCT‑58 impairs the cancer stem‑like phenotype and enhances chemotherapy efficacy in TNBCEunsun Jung, Yoon-Jae Kim, Kyoungmin Lee, et al.
Pageof 17